Position
Chief Executive Officer
Company
CytoDyn
VancouverBiotechnologyHealthcareHealth CareTherapeuticsDescription
CytoDyn Inc. , a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the appointment of Dr. Jacob Lalezari as interim CEO, effective November 17, 2023.
Quick answer
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO (November 21, 2023). CytoDyn is based in Vancouver, Washington, United States.
- Who is the new Chief Executive Officer at CytoDyn?
- CytoDyn named Jay Lalezari Chief Executive Officer, announced November 21, 2023.
- What did CytoDyn announce on November 21, 2023?
- CytoDyn Inc. , a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the appointment of Dr. Jacob Lalezari as interim CEO, effective November 17, 2023.
- What does CytoDyn do?
- CytoDyn is in late-stage clinical development of leronlimab, a CCR5 receptor antagonist, to be used as a platform drug for various therapeutic indications, including NASH, NASH/HIV, oncology, and HIV.
- Where is CytoDyn based?
- CytoDyn is based in Vancouver, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Madrigal Pharmaceuticals (November 21, 2023), MediWound Ltd (November 21, 2023), Chimerix (November 16, 2023) and Amylyx Pharmaceuticals (November 28, 2023) also announced leadership changes within 45 days of CytoDyn.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information Officer (November 21, 2023)
- MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer (November 21, 2023)
- Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer (November 16, 2023)
- Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer (November 28, 2023)
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer (November 9, 2023)
- Arbutus Announces CEO, William Collier, to Retire December 31, 2023 (November 7, 2023)
Who to call at CytoDyn, and when
A new leader at CytoDyn brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CytoDyn raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CytoDyn, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CytoDyn. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CytoDyn changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CytoDyn changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.